Skip to main content
. 2010 Jan 28;5(1):e8937. doi: 10.1371/journal.pone.0008937

Table 4. PMR's practices while selling medicines for a three year old febrile child.

Selling practices Kisii site Kwale site
I (n) % C (n) % P OR (95% CI) I (n) % C (n) % P OR (95% CI)
Sold anti-malarial with or without antipyretic* 40/43 (93.0%) 27/36 (75.0%) 0.032 4.4 (1.1, 17.9) 27/32 (84.4%) 23/42 (54.7%) 0.011 4.4 (1.4, 13.8)
Sold antipyretic only 3/43 (6.9%) 9/36 (25.0%) 0.026 0.2 (0.1, 0.9) 5/32 (15.6%) 19/42 (45.2%) 0.011 0.2 (0.1, 0.7)
Type of anti-malarial sold and adequacy of dosage
Sold AQ 38/43 (88.4%) 20/36 (55.6%) 0.002 6.1 (1.9, 19.0) 19/32 (59.4%) 8/42 (19.1%) <0.001 6.2 (2.2, 17.7)
Sold AQ with adequate advice 26/43 (60.5%) 1/36 (2.8%) <0.001 53.5 (6.7, 428.3) 6/32 (18.8%) 1/42 (2.3%) 0.038 9.4 (1.1, 83.1)
Sold AQ with adequate advice on dose/all AQ sold 26/38 (68.4%) 1/20 (5.0%) <0.001 41.2 (4.9, 344.4) 6/19 (31.6%) 1/8 (12.5%) 0.633 3.3 (0.3, 33.9)
Sold SP 2/43 (4.7%) 8/36 (22.2%) 0.037 0.2 (0.03, 0.9) 8/32 (25.0%) 15/42 (35.7%) 0.324 0.6 (0.2, 1.7)
Sold SP with adequate advice 0/36 (0%) 5/36 (13.8%) 0.017 NA 4/32 (12.5%) 8/42 (19.0%) 0.536 0.6 (0.2, 2.2)

*Note: the denominator was all medicines sold.

†the denominator is the outlets where either SP or AQ medicines were available at the time of the survey.